Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
13.38
-1.07 (-7.40%)
At close: May 12, 2025, 4:00 PM
13.50
+0.12 (0.90%)
After-hours: May 12, 2025, 6:17 PM EDT

Cadrenal Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
May '25 Dec '24 Dec '23 Dec '22
Market Capitalization
252610-
Market Cap Growth
239.36%168.05%--
Enterprise Value
18211-
Last Close Price
13.3814.4911.10-
PB Ratio
4.183.471.25-
P/TBV Ratio
4.113.471.25-
Debt / Equity Ratio
--0.00-0.11
Quick Ratio
4.003.7510.210.02
Current Ratio
4.323.7710.270.55
Return on Equity (ROE)
-208.59%-140.78%-780.59%-
Return on Assets (ROA)
-109.43%-73.49%-102.62%-
Return on Capital (ROIC)
-133.24%-90.41%-340.35%-
Earnings Yield
-51.03%-41.24%-86.73%-
FCF Yield
-40.48%-28.51%-36.67%-
Buyback Yield / Dilution
-43.28%-35.59%-70.99%-
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q